Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Glenmark Pharmaceuticals Limited
Press Release Oct 14 2020
Published Oct 14 2020
5 min read

Press Release Oct 14 2020

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 14, 2020, titled "Glenmark introduces NINDANIB (Nintedanib) and is amongst the first to launch the branded generic version at an affordable cost for the treatment of Pulmonary Fibrosis in India".

View Attachment